Publication: Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients.
Loading...
Identifiers
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Abstract
Description
Keywords
MeSH Terms
DeCS Terms
Bibliographic citation
Hemasphere . 2023 ;7(2):e829.





